A third phase of business reopenings began in Connecticut Thursday, loosening restrictions on occupancy for restaurants and other businesses as well as expanding the amount of people allowed at indoor and outdoor entertainment venues. “The reason why we are able to have a discussion about even entering into Phase 3 is because of Connecticut residents’ collective actions to fight the spread of COVID-19,” Gov. Ned Lamont said.
Want to get this in your inbox every Friday? Subscribe to Capitol Watch at courant.com/newsletters
The big story
Connecticut enters Phase 3 of business reopenings: The state’s coronavirus infection rate has been slowly creeping up but a third phase of business reopenings moved forward Thursday, allowing restaurants to seat more customers indoors, churches to hold larger indoor worship services and performing arts venues that have been shuttered since March to reopen at 50% capacity. “We just wanted to give our restaurants a little
NEW YORK & MIAMI–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in children 3 to <18 years of age with growth hormone deficiency (GHD), met its primary endpoint of improved treatment burden compared to GENOTROPIN® (somatropin) for injection administered once-daily.
Top-line results from the study demonstrated that treatment with somatrogon once-weekly improved the mean overall Life Interference total score after 12 weeks of treatment (8.63) compared to treatment with somatropin administered once-daily (24.13). The point estimate of the treatment difference was -15.49 (-19.71, -11.27 (95% CI); p<0.0001) in favor of somatrogon at the nominal 0.05 level. In addition, key secondary endpoints showed an overall benefit in treatment experience with the somatrogon once-weekly dosing regimen compared to the somatropin once-daily dosing regimen.
(Reuters) – Top U.S. and European central bankers on Tuesday called for renewed government spending to support families and businesses as the battle against the coronavirus-triggered recession enters a newly critical phase.
Hopes for new fiscal support in the United States, however, were dealt a serious blow when President Donald Trump abruptly canceled ongoing negotiations with Democrats in the U.S. House of Representatives.
The growth in new COVID-19 cases is again accelerating in parts of the United States and Europe, raising the prospect of new restrictions on commerce even as whole industries and millions of households are still reeling from those imposed in the spring during